Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY) -- Ignore unavailable to you. Want to Upgrade?

To: rkrw who wrote (687)	7/30/1998 2:19:00 AM
From: Bluegreen	Read Replies (2) \| Respond to of 3202

You wrote: "Now how about this? What if you bought shares in both INCY and XOMA at the annual high each year since the companies have been public, what would your returns look like? Here's a guess, down 97% in XOMA and up 500% in INCY. While certainly past history is not a reason not to own XOMA, it certainly provides a reason to tread carefully and steeped in reality." How does this information help ANYONE make money in high risk situations like Biotechs? I thought I made myself clear when I asked you before how such information would console you if you had bought INCY at the 52 week high and NOW you are just a little bit in the hole to put it mildly. Please don't tell me it is management's fault!!!!!! Now just in my humble opinion if Xoma and INCY are not bought out, I think a five bagger for each is PEANUTS compared to what these companies are capable of in the next 5 to 10 years.